1 

Registered Charity Number :- 800909 

M S INFORMATION & THERAPY CENTRE a Charitable Incorporated Organisation 

## TRUSTEES’ REPORT 

## AND 

## FINANCIAL STATEMENTS 

FOR THE YEAR END 31 December 2025 


**M S Information & Therapy Centre 71-75 Frampton Road** 

**Gloucester** 



## **M S INFORMATION & THERAPY CENTRE** 

## **CONTENTS** 

## **MS** 

FOR THE YEAR ENDED 31 December 2025 

TRUSTEES' REPORT ....................................................................................................................................................... 3 INDEPENDENT EXAMINER'S REPORT ....................................................................................................................... 6 STATEMENT OF FINANCIAL ACTIVITIES ................................................................................................................ 8 BALANCE SHEET ........................................................................................................................................................... 9 NOTES TO THE FINANCIAL STATEMENTS ............................................................................................................ 10 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**TRUSTEES' REPORT** 

FOR THE YEAR ENDED 31 December 2025 

The Management Committee present their report and the financial statements for the year ended 31 December 2025. 

Reference and Administrative Information 

Charity Name: M S Information and Therapy Centre Ltd 

Charity registration number:  800909 

Company registration number: 2294597 

Registered Office: 71-75 Frampton Road, Gloucester GL1 5QB 

## Trustees 

Nick Speed - Chair Vikki Sewell - Treasurer & Secretary Mike McCulloch - (Appointed 9[th] April 2025) John Prout Steven Hutchinson Paulene Fitchard Taffe – (Resigned 24[th] November 2025) Glenys Peat 

## Staff: 

Rachael Mason - Centre Manager Jade Barnes - Service Delivery Co-ordinator 

The Company, incorporated under the Companies Act 1985, on 9 September 1988, is Limited by Guarantee and does not have share capital. The registered office is 71-75 Frampton Road, Gloucester GL1 5QB 

## Objective 

The object for which the Centre was established was and is to aid and improve the condition of those diagnosed with neurological, long term or chronic conditions including Multiple Sclerosis, the area of operation being the Gloucestershire as well as neighbouring counties. 

## Public Benefit 

The Trustees are satisfied that the Charity's stated objective falls within the category "advancement of health" which is set out in the Charities Act 2011. The Charity meets this objective through the provision of oxygen therapy and other alternative, holistic and self-help therapies principally to people with Multiple Sclerosis but also to other members of the public who seek to obtain benefit from such therapies. 

The Trustees have complied with the Charities Act 2011 and their duty to 'have regard' to public benefit guidance provided by the Charity Commission when exercising powers or duties to which the guidance is relevant. 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**TRUSTEES' REPORT** 

FOR THE YEAR ENDED 31 December 2025 

## Principal Activity 

The main activity of the Charity continues to be the provision of oxygen therapy and other alternative, holistic and self-help therapies which are provided at the charities building in Frampton Road Gloucester. This building enables an extended range of services to be made available for the benefit of members. Apart from the provision of oxygen therapy, the therapies provided are by independent providers and not directly by the Charity. 

The Charcot Therapy Centre does not receive any statutory funding. We rely heavily on fundraising, donations, and grants to continue our work, and we are deeply grateful to everyone who raises funds or organises activities in support of the Centre 

During 2025, we undertook a major programme of modernisation. The Centre has moved to an almost fully paperless system, supported by the installation of a new CRM platform and a streamlined, digitised phone system. These changes have improved efficiency, reduced administrative burden, and enabled quicker, more accurate communication with our members. Alongside this, we significantly increased our marketing and social media activity, helping us reach more people and strengthen community engagement. 

We also completed a full reassessment of our workshops. In response to the current economic climate and the pressures faced by our community, we have refined and refocused our programme to ensure it meets the real needs of our members. The result is a more targeted, relevant, and sustainable offer, almost a soft rebrand that aligns our activities with the lived experiences of the people we support. 

Looking ahead, we are preparing to introduce online therapy bookings in 2026, alongside new social media subscription options to support ongoing engagement and conversation within our community. 

Our partnership with the local NHS has also deepened. We now host more MS clinics each week and introduced MND clinics, with plans to expand further in collaboration with the neurological department. Our safe, informed, and welcoming environment has become a valued space for clinical teams and service users alike. 

We have continued to build on the strategic foundations established in 2024, strengthening our governance, training, and organisational development throughout 2025, alongside several key enhancements that support our long-term sustainability. 

A significant focus has been the review and modernisation of our Articles of Association. This process has helped ensure that our governance framework reflects both current best practice and the practical realities of how the Centre operates today. 

Our trustee board development has been another key area of progress. We have introduced a refreshed structure that aligns trustees’ skills and lived experience with specific areas of governance, ensuring that everyone’s strengths are used to best effect. To encourage innovation and shared leadership, we have also implemented a rolling Chair arrangement, supporting fresh perspectives and a dynamic approach to decision-making. 

We have begun work on a new fundraising strategy in collaboration with our local VCSE support partners. This will help us diversify income, strengthen long-term sustainability, and ensure we can continue delivering high-quality services and therapies for our community. 

Finally, we have improved the physical layout of the Centre to make it more accessible, welcoming, and functional. Administrative staff are now easier to reach, the flow of the building is more intuitive, and the installation of a new door and window has enhanced the aesthetics of the social area, strengthened peer-to-peer support and creating a more inviting community space. 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**TRUSTEES' REPORT** 

FOR THE YEAR ENDED 31 December 2025 

## Review of Activities 

The Centre continues to provide a wide range of therapies to its members. We are pleased to confirm that the charity in 2025 has provided: 

- 403 Active Members (increase 13.2%) 

- 12 Therapists & 11 Oxygen operators & 25 Volunteers 

- 18 Different Therapies & Workshops Available 

- 4423 Oxygen Therapy Sessions Delivered (increase 0.6%) 

- 227 Acupuncture Sessions (increase 12.7%) 

- 446 Massage Sessions (decrease 8.9%) 

- 436 Talking Therapy / CST Participations (increase 20.1%) 

- 1001 Pilates Participations (increase 7.2%) 

- 63 Foot Health session (new service) 

## Reserves Policy 

The trustees regularly review and update the reserves policy in line with on-going commitments. 

The management committee have agreed that the target level of free reserves is 6 months' expenditure, which is £25,056. 

The National Lottery payments throughout the year remain restricted funds. 

## Future Plans 

These priorities for the next 3 years have been shaped by our existing experience, and drawing on knowledge from our sector, our wider network, and from our own membership cohort, working in collaboration to produce a highquality service and a secure sustainable future. 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**INDEPENDENT EXAMINER'S REPORT** 

FOR THE YEAR ENDED 31 December 2025 

## **INDEPENDENT EXAMINER’S REPORT TO THE** 

## **TRUSTEES’ OF** 

## **M S Information and Therapy Centre Ltd** 

I report to the trustees on my examination of the accounts of the above charity for the year ended 31[st ] December 2025 

**Responsibilities and basis of the report** 

As the charity's trustees, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”). 

I report in respect of my examination of the charities’ accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**INDEPENDENT EXAMINER'S REPORT** 

FOR THE YEAR ENDED 31 December 2025 

## **Independent examiner’s statement** 

I have completed my examination.  I confirm that no material matters have come to my attention in connection with the examination (other than that disclosed below *) which gives me cause to believe that in, any material respect: 

· the accounting records were not kept in accordance with section 130 of the Charities Act; or 

· the accounts did not accord with the accounting records; or 

· the accounts did not comply with the applicable requirements concerning the form and content of accounts set out in the Charities Regulations 2008 other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Mr M Marshall FCCA 

Pi Accountancy 

………………………………… 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**STATEMENT OF FINANCIAL ACTIVITIES** 

FOR THE YEAR ENDED 31 December 2025 

|**Recommended**<br>**categories by activity**<br>**Notes**<br>**Incoming resources**<br>**Income and**<br>**endowments from:**<br>Donations and<br>legacies<br>2<br>Other trading<br>activities<br>3<br>Investments<br>4<br>**Total**<br>**Resources expended**<br>**Expenditure on:**<br>Raising funds<br>5<br>Charitable activities<br>6<br>**Total**<br>**Net**<br>**income/(expenditure)**<br>**before investment**<br>**gains/(losses)**<br>Reconciliation of<br>funds:<br>Total funds brought<br>forward<br>**Total funds carried**<br>**forward**|**Unrestricted**<br>**funds**<br>**£**<br>**Restricted**<br>**income**<br>**funds**<br>**£**<br>**Total**<br>**Funds 2025**<br>**£**<br>**Total**<br>**Funds 2024**<br>**£**<br>107,396<br>40,737<br>148,133<br>138,680<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>138|
|---|---|
||107,396<br>40,737<br>148,133<br>138,818|
||17,073<br>-<br>17,073<br>14,608<br>108,331<br>17,250<br>125,581<br>133,557|
||**125,404**<br>**17,250**<br>142,654<br>**148,165**|
||**(18,008)**<br>23,487<br>5,479<br>**(9,347)**<br>(16,601)<br>61,452<br>44,851<br>54,198|
||(34,609)<br>84,939<br>50,330<br>44,851|





**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**BALANCE SHEET** 

## FOR THE YEAR ENDED 31 December 2025 

|**Recommended categories by**<br>**activity**<br>**Notes**<br>Fixed assets<br>Tangible assets<br>8<br>**Total fixed assets**<br>Current assets<br>Stocks<br>Debtors<br>9<br>Cash at bank and in hand<br>10<br>**Total current assets**<br>Creditors: amounts falling due<br>within one year<br>11<br>**Net current assets/(liabilities)**<br>**Total assets less current liabilities**<br>**Total net assets or liabilities**|**Unrestricted funds**<br>**£**<br>**Total Funds 2025**<br>**£**<br>**Total Funds 2024**<br>**£**<br>12,903<br>12,903<br>10,651|
|---|---|
||12,903<br>12,903<br>10,651|
||1,500<br>1,500<br>950<br>4,826<br>4,826<br>4,826<br>32,947<br>32,947<br>31,183<br>39,273<br>**39,273**<br>36,959<br>1,846<br>1,846<br>2,759<br>37,427<br>**37,427**<br>34,200|
||50,330<br>50,330<br>44,851|
||50,330<br>50,330<br>44,851|



The financial statements were approved by the Board on ……….  and signed on its behalf by: 

Trustee 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**NOTES TO THE FINANCIAL STATEMENTS** 

FOR THE YEAR ENDED 31 December 2025 

## **ACCOUNTING POLICIES** 

## **Basis of preparation and assessment of going concern** 

The financial statements have been prepared under the historical cost convention. The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102),the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP FRS 102) and the Companies Act 2006. 

The charitable company meets the definition of a public benefit entity under FRS 102. The Trustees consider that there are no material uncertainties about the charitable company's ability to continue as a going concern. The financial statements are presented in sterling (£) and are rounded to the nearest £. 

## **Income** 

Income, excluding donations, is included in the financial statements using the accruals concept. Grants are recognised when the entitlement, certainty and measurement conditions have been met. Donations are included as and when received. Income tax recoverable on gift aided donations is included in the period in which it is received. 

Gifts in kind received for resale are recognised when the gift is sold using the sales value. The contribution of volunteers is not included in the Statement of Financial Activities. 

## **Expenditure** 

The cost of generating funds includes costs of generating voluntary income. Charitable activities costs include expenditure on delivering oxygen therapy. 

## **Liabilities** 

Liabilities are recognised in the accounts as soon as a present obligation arises from a past event that will probably result in a transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. 

## **Fund accounting** 

General funds are expendable at the discretion of the Trustees in furtherance of the charity's objects and which have not been designated for other purposes. 

In light of the size of the charity, its policy is to build up a reserve of at least one year’s operating costs. Restricted funds contain income which has been received for specific purposes, less the related expenditure against these. 

## **Leasing commitments** 

Rentals paid under operating leases are charged to the statement of financial activities as incurred. 

## **Pensions** 

The pension costs represent amounts payable by the charity during the year. 

## **Stocks** 

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. 

## **Allocation of support costs** 

The only material allocation of support costs is the salary of the only employee of the charity. 25% of their cost is allocated to fundraising and 75% to charitable activities which is thought to be a reasonable allocation reflecting the time spent on these activities. 



**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**NOTES TO THE FINANCIAL STATEMENTS** 

FOR THE YEAR ENDED 31 December 2025 

## **Tangible fixed assets** 

Tangible fixed assets are included at cost. 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life, an entire year’s depreciations is applied to a financial year regardless as to when the asset was purchased in the year. Rates applied are: 

- Oxygen Chamber: 15% on reducing balance 

- Fixtures and fittings: 16.6% straight line 

- Computers: 33.3% straight line 

Donated assets given for use by the charity are recognised at their market value as incoming resources and within the relevant fixed asset category on the balance sheet when receivable 

## **Income from Donations and Legacies** 

|**Analysis**<br>Donation and gifts<br>General grants provided by<br>Government/other charities<br>Restricted Donations &<br>Legacies<br>**4 Income from Investments**<br>**Analysis**<br>Interest income|**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds 2025**<br>**Total funds 2024**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>92,368<br>-<br>-<br>92,368<br>79,726<br>15,028<br>-<br>-<br>15,028<br>10,902<br>-<br>40,737<br>-<br>40,737<br>48,052|
|---|---|
||107,396<br>40,737<br>-<br>148,133<br>138,680|
||**Unrestricted**<br>**funds**<br>**Restricted**<br>**income**<br>**funds**<br>**Endowment**<br>**funds**<br>**Total funds 2025**<br>**Total funds 2024**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-<br>-<br>-<br>-<br>138|
||-<br>-<br>-<br>-<br>138|





**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**NOTES TO THE FINANCIAL STATEMENTS** 

FOR THE YEAR ENDED 31 December 2025 

## **5 Expenditure on Raising Funds** 

||**Total funds 2025**|**Total funds 2024**|
|---|---|---|
|**Analysis**|**£**|**£**|
|Other trading activities|3,508|610|
|Wages and salaries|13,565|13,998|
|Support Costs|-|-|
||17,073|14,608|
|**6 Expenditure on Charitable Activities**|||
||**Total funds 2025**|**Total funds 2024**|
|**Analysis**|**£**|**£**|
|Charity management &<br>administration|13,555|7,686|
|Charity running cost|36,593|49,347|
|Cost of services|9,070|11,010|
|Employee costs|5,951|3,796|
|Donations|-|1,033|
|Bank charges|-|-|
|Wages and salaries|40,695|41,996|
|Restricted – Rent|17,250|17,250|
|Support Costs|2,467|1,439|
||125,581|133,557|



## **6 Expenditure on Charitable Activities** 

## **6.1  Operating Costs** 

||**2025**<br>|**2024**|
|---|---|---|
||**£**<br>|**£**|
|**Operating leases – Land and Buildings**|**17,250**<br>|**17,250**|
|**Depreciation of fixed assets**|**5,873**<br>|**5,968**|





**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**NOTES TO THE FINANCIAL STATEMENTS** 

FOR THE YEAR ENDED 31 December 2025 

## **7 Support Costs** 

|**Analysis**<br>**Governance Costs**<br>Independent examiners fees<br>**8 Tangible Fixed Assets**|**Total funds 2025**<br>**Total funds 2024**<br>**£**<br>**£**<br>1,350<br>1,439|
|---|---|
||1,350<br>**1,439**|
|||



## **8.1 Cost or valuation** 

|At 01 January 2025<br>Additions<br>Disposals<br>Revaluations<br>Transfers<br>At 31 December 2025|**Plant & Machinery**<br>**Fixtures & Fittings**<br>**Computer Equipment**<br>**£**<br>**£**<br>**£**<br>39,183<br>45,659<br>2,516<br>4,961<br>1,675<br>1,487<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-|
|---|---|
||44,144<br>47,334<br>4,003|



## **8.2 Amortisation and impairments** 

|At 01 January 2025<br>Depreciation charges<br>Disposals<br>Revaluations<br>Transfers<br>At 31 December 2025<br>**8.3 Net book value**<br>At 01 January 2025<br>At 31 December 2025|**Plant & Machinery**<br>**Fixtures & Fittings**<br>**Computer Equipment**<br>**£**<br>**£**<br>**£**<br>29,041<br>45,556<br>2,108<br>4,739<br>387<br>748<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-|
|---|---|
||33,780<br>45,943<br>2,856|
||**Plant & Machinery**<br>**Fixtures & Fittings**<br>**Computer Equipment**<br>**£**<br>**£**<br>**£**<br>10,141<br>103<br>407|
||10,364<br>1,391<br>1,147|





**M S INFORMATION & THERAPY CENTRE** 

**MS** 

**NOTES TO THE FINANCIAL STATEMENTS** 

FOR THE YEAR ENDED 31 December 2025 

## **9 Debtors: Amounts falling due within one year** 

||**Total**|**funds 2025**|**Total funds 2024**|
|---|---|---|---|
|||**£**|**£**|
|Prepayments & accrued income||4,826|4,826|
|**10 Cash at bank and in hand**||||
||**Total funds**|**2025**|**Total funds 2024**|
||**£**||**£**|
|Cash at bank and on hand|32,947||31,183|
|Other|-||-|
||32,947||31,183|
|**11 Creditors: Amounts falling due within one year**||||
||**Total**|**funds 2025**|**Total funds 2024**|
|||**£**|**£**|
|Trade creditors||-|-|
|Accruals and deferred income||1,350|2,030|
|Taxation and social security||495|729|
|||1,845|2,759|
|**12 Charity funds**||||



## **12.1 Details of material funds held and movements during the CURRENT reporting period** 

|**Fund names**<br>**Unrestricted funds**<br>**General Fund**<br>**Restricted Funds**<br>**Total**|**Fund balances**<br>**brought**<br>**forward**<br>**Income**<br>**Expenditure**<br>**Transfers**<br>**Gains and**<br>**losses**<br>**Fund balances**<br>**carried**<br>**forward**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>(16,601)<br>107,396<br>(125,404)<br>-<br>-<br>(34,609)<br>61,452<br>40,737<br>(17,250)<br>-<br>-<br>84,939|
|---|---|
||44,851<br>148,133<br>(142,654)<br>-<br>-<br>50,330|



